SynBalance

SynBalance is an Italian biotechnology company and spin-off of ROELMI HPC, specialized in the design, development, and manufacture of high-quality, clinically tested probiotic strains and related microbiome solutions. Operating within the nutraceutical industry, the company utilizes advanced bio-fermentation technology to create proprietary strains of Lactobacilli, Bifidobacteria, and other species. Their R&D process incorporates in-vitro and ex-vivo screening alongside human clinical trials to ensure scientific efficacy, focusing on functional areas such as intestinal health, the gut-skin axis, cardiometabolic risk, immune modulation, and mental health. The company also offers inactivated bacterial strains, known as postbiotics, to expand compatibility with various active ingredients.

Serving both small and multinational partners, SynBalance provides a versatile service model that includes raw material supply, branded and tailor-made formulations, white-label production, and licensing of ready-to-go product concepts. By providing comprehensive product dossiers and regulatory support, the company enables its partners to accelerate time-to-market and develop personalized, evidence-based health strategies. Their business is supported by an integrated management system compliant with international standards, emphasizing quality, safety, and a commitment to modulating the human microbiota to support long-term health and wellness.